HPGC Renmintongtai Pharmaceutical Corp (600829) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.063x

Based on the latest financial reports, HPGC Renmintongtai Pharmaceutical Corp (600829) has a cash flow conversion efficiency ratio of -0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-187.38 Million ≈ $-27.42 Million USD) by net assets (CN¥2.99 Billion ≈ $437.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

HPGC Renmintongtai Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how HPGC Renmintongtai Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 600829 current and long-term liabilities for a breakdown of total debt and financial obligations.

HPGC Renmintongtai Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HPGC Renmintongtai Pharmaceutical Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Black Diamond Group Limited TO:BDI	0.046x
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	0.000x
Shandong Weida Machinery Co Ltd SHE:002026	0.025x
Jiangsu Allfavor Intelligent Circuits Technology CO.Ltd SHE:300964	0.006x
Citic Guoan Wine Co Ltd SHG:600084	0.005x
Haoxiangni Jujube Co Ltd SHE:002582	0.029x
Metals Acquisition Limited NYSE:MTAL	0.068x
Haining China Leather Market Co Ltd SHE:002344	-0.024x

Annual Cash Flow Conversion Efficiency for HPGC Renmintongtai Pharmaceutical Corp (1998–2024)

The table below shows the annual cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see HPGC Renmintongtai Pharmaceutical Corp market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.88 Billion ≈ $421.60 Million	CN¥115.44 Million ≈ $16.89 Million	0.040x	-66.89%
2023-12-31	CN¥2.75 Billion ≈ $402.61 Million	CN¥332.99 Million ≈ $48.73 Million	0.121x	-3.02%
2022-12-31	CN¥2.46 Billion ≈ $360.36 Million	CN¥307.33 Million ≈ $44.97 Million	0.125x	+217.79%
2021-12-31	CN¥2.20 Billion ≈ $321.82 Million	CN¥-233.00 Million ≈ $-34.10 Million	-0.106x	-2188.91%
2020-12-31	CN¥1.99 Billion ≈ $291.54 Million	CN¥-9.22 Million ≈ $-1.35 Million	-0.005x	+97.92%
2019-12-31	CN¥1.85 Billion ≈ $270.31 Million	CN¥-411.60 Million ≈ $-60.23 Million	-0.223x	-196.07%
2018-12-31	CN¥1.58 Billion ≈ $231.19 Million	CN¥366.45 Million ≈ $53.62 Million	0.232x	+168.84%
2017-12-31	CN¥1.61 Billion ≈ $235.89 Million	CN¥139.07 Million ≈ $20.35 Million	0.086x	+208.97%
2016-12-31	CN¥1.65 Billion ≈ $241.12 Million	CN¥46.01 Million ≈ $6.73 Million	0.028x	-88.10%
2015-12-31	CN¥1.42 Billion ≈ $208.27 Million	CN¥333.99 Million ≈ $48.87 Million	0.235x	+28.70%
2014-12-31	CN¥2.15 Billion ≈ $315.05 Million	CN¥392.58 Million ≈ $57.45 Million	0.182x	+360.00%
2013-12-31	CN¥2.26 Billion ≈ $330.33 Million	CN¥-158.31 Million ≈ $-23.17 Million	-0.070x	-172.98%
2012-12-31	CN¥2.31 Billion ≈ $337.41 Million	CN¥221.57 Million ≈ $32.42 Million	0.096x	+271.75%
2011-12-31	CN¥1.94 Billion ≈ $283.25 Million	CN¥-108.30 Million ≈ $-15.85 Million	-0.056x	-159.69%
2010-12-31	CN¥1.74 Billion ≈ $254.43 Million	CN¥162.99 Million ≈ $23.85 Million	0.094x	-65.32%
2009-12-31	CN¥1.66 Billion ≈ $242.41 Million	CN¥447.82 Million ≈ $65.53 Million	0.270x	+776.00%
2008-12-31	CN¥1.65 Billion ≈ $241.27 Million	CN¥-65.93 Million ≈ $-9.65 Million	-0.040x	-129.42%
2007-12-31	CN¥1.41 Billion ≈ $205.71 Million	CN¥191.10 Million ≈ $27.96 Million	0.136x	-22.95%
2006-12-31	CN¥1.08 Billion ≈ $158.53 Million	CN¥191.13 Million ≈ $27.97 Million	0.176x	-49.94%
2005-12-31	CN¥888.23 Million ≈ $129.98 Million	CN¥313.04 Million ≈ $45.81 Million	0.352x	+504.14%
2004-12-31	CN¥1.04 Billion ≈ $152.24 Million	CN¥60.69 Million ≈ $8.88 Million	0.058x	-54.38%
2003-12-31	CN¥560.39 Million ≈ $82.00 Million	CN¥71.65 Million ≈ $10.48 Million	0.128x	-47.23%
2002-12-31	CN¥526.17 Million ≈ $77.00 Million	CN¥127.49 Million ≈ $18.66 Million	0.242x	+720.86%
2001-12-31	CN¥501.11 Million ≈ $73.33 Million	CN¥14.79 Million ≈ $2.16 Million	0.030x	-77.75%
2000-12-31	CN¥466.36 Million ≈ $68.24 Million	CN¥61.85 Million ≈ $9.05 Million	0.133x	-3.81%
1999-12-31	CN¥422.13 Million ≈ $61.77 Million	CN¥58.21 Million ≈ $8.52 Million	0.138x	+44.85%
1998-12-31	CN¥430.69 Million ≈ $63.02 Million	CN¥41.00 Million ≈ $6.00 Million	0.095x	--

About HPGC Renmintongtai Pharmaceutical Corp

SHG:600829 China Drug Manufacturers - Specialty & Generic

Market Cap

$835.83 Million

CN¥5.71 Billion CNY

Market Cap Rank

#10005 Global

#2849 in China

Share Price

CN¥9.85

Change (1 day)

+1.34%

52-Week Range

CN¥7.17 - CN¥17.72

All Time High

CN¥17.72